Imaging of Prostate Cancer Using Two-dimensional MR Spectroscopy and Diffusion Tensor Imaging

Withdrawn before enrolling · Not applicable

Conditions studied: Prostate Lesions

In brief

The goal is to develop MR imaging techniques to improve delineation of cancer extent, and to improve differential diagnosis between prostate cancer and benign prostate hyperplasia or other benign diseases.

Key facts

Study ID

NCT00611065

Run by

University of California, Irvine

People needed

0

Starts

2007-06-01

Last updated by the study team

2018-07-20

Who can join

Age: 21 and older, up to 80. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• A male older than 21 years of age and under age of 80,
• Either a normal healthy volunteer; a patient who has confirmed prostate cancer and decided to receive prostatectomy; or a patient who has persistent elevated PSA higher than 4.0 ng/ml, and with a prior benign biopsy scheduled to receive the second biopsy.

You may not qualify if…

• Unwilling to give informed consent,
• Have implanted prosthetic heart valves, pacemaker, neuro-stimulation devices, surgical clips (hemostatic clips) or other metallic implants,
• Have engaged in occupations or activities which may cause accidental lodging of ferromagnetic materials, or have imbedded metal fragments from military activities,
• Have received orthodontic work involving ferromagnetic materials,
• Claustrophobic,
• Unable to lie down still for 60 minutes.

Where it is running

• Center for Functional Onco-Imaging, University of California — Irvine, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.